The Conversation (0)
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) has released its fourth quarter and year-end 2012 financial results and operational update. According to the company, its revenue for the fourth quarter was $2 million and its annual income was $5.9 million.
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) has released its fourth quarter and year-end 2012 financial results and operational update. According to the company, its revenue for the fourth quarter was $2 million and its annual income was $5.9 million.
As quoted in the press release:
Net income for the fourth quarter ended December 31, 2012 was $28.4 million, which included the operating loss of $6.0 million and non-cash income of $34.4 million related to changes in the fair value of the Company’s outstanding and exercised warrants that was classified as other income (expense). Net loss for the year ended December 31, 2012 was $71.1 million, which included the operating loss of $20.0 million and non-cash expense of $51.2 million related to changes in the fair value of the Company’s outstanding and exercised warrants.
Click here to read the full Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) press release.
